alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
* Pursuant to 5TH CIR. R. 47.5, the court has determined

that this opinion should not be published and is not precedent

except under the limited circumstances set forth in 5TH CIR.

R. 47.5.4.

United States Court of Appeals

Fifth Circuit

FILED

April 24, 2003

Charles R. Fulbruge III

Clerk

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

 

No. 02-40577

Conference Calendar

 

UNITED STATES OF AMERICA,

Plaintiff-Appellee,

versus

VICTOR MANUEL MENDOZA-OCHOA, also known as

Tomas Claro-Alfaro,

Defendant-Appellant.

--------------------

Appeal from the United States District Court

for the Southern District of Texas

USDC No. M-01-CR-754-1

--------------------

Before DAVIS, BARKSDALE, and STEWART, Circuit Judges.

PER CURIAM:*

Victor Manuel Mendoza-Ochoa appeals from his guilty-plea

conviction of possession with intent to distribute cocaine. He

contends, for the first time on appeal, that 21 U.S.C. § 841 was

rendered unconstitutional by Apprendi v. New Jersey, 530 U.S. 466

(2000), because drug types and quantities should be treated as

elements of the offense of possession with intent to distribute. 

Mendoza concedes that his argument runs counter to this court’s
No. 02-40577

-2-

caselaw; he raises the issue to preserve it for Supreme Court

review.

Because Mendoza did not raise his Apprendi issue in the

district court, his contention is reviewed under the plain-error

standard. United States v. Vasquez, 298 F.3d 354, 356 (5th

Cir.), cert. denied, 123 S. Ct. 546 (2002). Apprendi did not

render 21 U.S.C. § 841 facially unconstitutional. Id. at 360. 

Mendoza has not shown error, plain or otherwise.

AFFIRMED.
# Official Journal C 149/2020

| | ISSN 1977-091X |
| --- | --- |
| Official Journal
  of the European Union | C 149 |
| | |
| English edition | Information and Notices | Volume 635 May 2020 |

ISSN 1977-091X

Official Journal

of the European Union

C 149

English edition

Information and Notices

Volume 635 May 2020

---

| Contents | page |
| --- | --- |
| | III   Preparatory acts |
| | Council |
| 2020/C 149/01 | Position (EU) No 4/2020 of the Council at first reading with a view to the adoption of a Directive of the European Parliament and of the Council laying down specific rules with respect to Directive 96/71/EC and Directive 2014/67/EU for posting drivers in the road transport sector and amending Directive 2006/22/EC as regards enforcement requirements and Regulation (EU) No 1024/2012 Adopted by the Council on 7 April 2020 | 1 |
| 2020/C 149/02 | Statement of the Council’s reasons: Position (EU) No 4/2020 of the Council at first reading with a view to the adoption of a Directive of the European Parliament and of the Council laying down specific rules with respect to Directive 96/71/EC and Directive 2014/67/EU for posting drivers in the road transport sector and amending Directive 2006/22/EC as regards enforcement requirements and Regulation (EU) No 1024/2012 | 18 |

Contents

page

III   Preparatory acts

Council

2020/C 149/01

Position (EU) No 4/2020 of the Council at first reading with a view to the adoption of a Directive of the European Parliament and of the Council laying down specific rules with respect to Directive 96/71/EC and Directive 2014/67/EU for posting drivers in the road transport sector and amending Directive 2006/22/EC as regards enforcement requirements and Regulation (EU) No 1024/2012 Adopted by the Council on 7 April 2020

1

2020/C 149/02

Statement of the Council’s reasons: Position (EU) No 4/2020 of the Council at first reading with a view to the adoption of a Directive of the European Parliament and of the Council laying down specific rules with respect to Directive 96/71/EC and Directive 2014/67/EU for posting drivers in the road transport sector and amending Directive 2006/22/EC as regards enforcement requirements and Regulation (EU) No 1024/2012

18

---

| EN | |
| --- | --- |

EN
```

[Federal Register Volume 89, Number 221 (Friday, November 15, 2024)]
[Notices]
[Page 90283]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-26700]

[[Page 90283]]

-----------------------------------------------------------------------

EXPORT-IMPORT BANK

[Public Notice: 2021-3095]

Agency Information Collection Activities: Submission to the 
Office of Management and Budget for Review and Approval; Comment 
Request; EIB 95-09 Export-Import Bank Letter of Interest Application

AGENCY: Export-Import Bank of the United States.

ACTION: Notice of information collection; request for comment.

-----------------------------------------------------------------------

SUMMARY: The Export-Import Bank of the United States (EXIM), pursuant 
to the Export-Import Bank Act of 1945, as amended, facilitates the 
finance of the export of U.S. goods and services. As part of its 
continuing effort to reduce paperwork and respondent burden, EXIM 
invites the general public and other Federal agencies to comment on the 
proposed information collection, as required by the paperwork Reduction 
Act of 1995.

DATES: Comments must be received on or before December 16, 2024 to be 
assured of consideration.

ADDRESSES: Comments may be submitted electronically on 
www.regulations.gov (EIB 95-09) or by mail to Office of Information and 
Regulatory Affairs, 725 17th Street NW, Washington, DC 20038 Attn: OMB 
3048-0005 EIB 95-09. The form can be reviewed at https://img.exim.gov/s3fs-public/pub/pending/EIB+95-09+Letter+of+Interest+Application_08_2024.pdf.

FOR FURTHER INFORMATION CONTACT: To request additional information, 
please contact Donna Schneider, [email protected], 202-565-3612.

SUPPLEMENTARY INFORMATION: The Letter of Interest (LI) is an indication 
of Export-Import (EXIM) Bank's willingness to consider financing a 
given export transaction. EXIM uses the requested information to 
determine the applicability of the proposed export transaction and 
determines whether or not to consider financing that transaction.
    Title and Form Number: EIB 95-09 Letter of Interest Application.
    OMB Number: 3048-0005.
    Type of Review: Regular.
    Need and Use: The Letter of Interest (LI) is an indication of 
Export-Import (EXIM) Bank's willingness to consider financing a given 
export transaction. EXIM uses the requested information to determine 
the applicability of the proposed export transaction system prompts and 
determines whether to consider financing that transaction.
    Affected Public: This form affects entities involved in the export 
of U.S. goods and services.
    Annual Number of Respondents: 400.
    Estimated Time per Respondent: 0.75 hours.
    Annual Burden Hours: 300.
    Frequency of Reporting of Use: On occasion.

Andrew Smith,
Records Officer.
[FR Doc. 2024-26700 Filed 11-14-24; 8:45 am]
BILLING CODE 6690-01-P
```
----

National reference laboratory designated by Norway in accordance with Council Decision 1999/313/EC on reference laboratories for monitoring bacteriological and viral contamination of bivalve molluscs

(2005/C 40/12)

----
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection
with the Amendment No. 1 to the Annual Report on Form 10-K of American Express
Credit Corporation (the Company) for the fiscal year ended December 31, 2008,
as filed with the Securities and Exchange Commission on the date hereof (the
Report), David L. Yowan, as Chief Executive Officer of the Company, hereby
certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, that:

| |     |                                                                                                                                                       
| | --- | ------------------------------------------------------------------------------------------------------------------------------------------------------
| | (1) | The Report
 fully complies with the requirements of Section 13(a) or 15(d) of the
 Securities Exchange Act of 1934; and                               
| |     |                                                                                                                                                       
| | (2) | The
 information contained in the Report fairly presents, in all material
 respects, the financial condition and results of operations of the Company.

|                   |                         
|------------------ | ------------------------
|/s/David L.
 Yowan
|                  
|Name:              | David L.
 Yowan         
|Title:             | Chief
 Executive Officer
|Date:              | November 16,
 2009      

The foregoing
certification is being furnished solely pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and is not
being filed as part of the Form 10-K/A or as a separate disclosure document
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended
(the Exchange Act), or otherwise subject to liability under that section.
This certification shall not be deemed to be incorporated by reference into any
filing under the Securities Act of 1933, as amended, or the Exchange Act except
to the extent that this Exhibit 32.1 is expressly and specifically incorporated
by reference in any such filing.

A signed
original of this written statement required by Section 906 has been provided to
the Company and will be retained by the Company and furnished to the Securities
and Exchange Commission or its staff upon request.

---
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Center for Complementary and Integrative Health Special Emphasis Panel; NCCIH Conference Grant (R13 Clinical Trial Not Allowed).                    

*Date:*                         December 10, 2024                    

*Time:*                         2:00 p.m. to 3:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Address:*                         National Center for Complementary and Integrative, Democracy II, 6707 Democracy Blvd., Bethesda, MD 20892.                    

*Meeting Format:*                         Virtual Meeting.                    

*Contact Person:*                         Michael E. Authement, Ph.D., Scientific Review Officer, Office of Scientific Review, Division of Extramural Activities, 6707 Democracy Boulevard, Bethesda, MD 20817,                         *michael.authement@nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.213, Research and Training in Complementary and Alternative Medicine, National Institutes of Health, HHS)

Dated: November 8, 2024. 

David W. Freeman, 

Supervisory Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2024-26562 Filed 11-14-24; 8:45 am]

BILLING CODE 4140-01-P
Exhibit 10.5
                                                                    ------------


                                                                  March 2, 2001



Mr. Michael G. Stout
609 Hampshire Court
Carmel, IN 46032-9485

Dear Mike:

         This letter is intended  to  document  the terms  pursuant to which you
have agreed to serve as Chairman of UAC.

         Your employment is effective February 23, 2001. You have been appointed
Chairman  of UAC as of such  date.  You  will  devote  substantially  your  full
business time and attention to the  management and affairs of UAC. While we have
a mutual  understanding  that this  arrangement  will be in effect for two years
from such date,  your  employment  is at will and may be  terminated at any time
with or without cause by the Board of Directors.

         While you are employed by UAC,  for the two years  ending  February 23,
2003, you will be entitled to an annual salary of $225,000.  You have requested,
and UAC has  agreed,  that  payment of such  salary  (while it will  accrue from
February  23,  2001)  shall be deferred  until the earlier of (i) a  significant
equity  capital  raising  transaction  by UAC,  (ii)  change of  control  of the
Company, or (iii) January 2, 2002. The accrued amount will be paid in a lump sum
at that time,  subject to applicable  withholding  amounts,  and thereafter your
salary will be paid in accordance with UAC's regular payroll practices.

         You have been awarded stock options for 300,000 shares under UAC's 1999
Incentive  Stock Plan.  This award is  represented  by a separate  stock  option
agreement. You understand that the exercisability of some or all of such options
will be subject to  shareholder  approval of the plan  amendment  increasing the
shares authorized for issuance  thereunder.  The board of directors has directed
that  such  amendment  be  presented  for  shareholder   approval  at  the  next
shareholders' meeting. Richard D. Waterfield has informed UAC that he intends to
support approval of such amendment.

         During your  employment,  you will be eligible to  participate  in such
benefit plans and  arrangements as UAC makes  available to its senior  executive
officers generally;  provided, that you will not participate in the Annual Bonus
and Deferral Plan for Senior Officers.

         This letter  agreement  is  effective  as of  February  23,  2001,  but
executed as of the date  written  above.  It is governed  by Indiana  law.  Your
rights and  obligations  hereunder  are personal to you and are not  assignable.

         Mike, if this letter accurately sets forth our agreement regarding your
employment, please sign below to acknowledge that fact.


                                                Union Acceptance Corporation


                                                By: /s/ John M. Stainbrook
                                                   -----------------------------
                                                   John M. Stainbrook, President

AGREED:

/s/ Michael G. Stout
--------------------------
Michael G. Stout
**Certification**

                      Pursuant to 18 U.S.C. § 1350, theundersigned officer of Alcan Inc. (the "Company"), hereby certifies, to suchofficer's knowledge, that the Company's Annual Report on Form 10-K for the year ended December 31, 2004 (the "Report") fully complieswith the requirements of Section 13(a) of the Securities Exchange Act of 1934and that the information contained in the Report fairly presents, in allmaterial respects, the financial condition and results of operations of theCompany.

 

| Date: 14 March 2005 | /s/ GeofferyE. Merszei                |
|---------------------|------------------------------------------------------------------------------------------------------------------|
|                | GeofferyE. Merszei                                                                                               |
|                | Executive Vice President and                                                                                     |
|                | Chief Financial Officer                                                                                          |

** **
# Official Journal C 405A/7 Oc

| | ISSN 1977-091X |
| --- | --- |
| Official Journal
  of the European Union | C 405A |
| | |
| English edition | Information and Notices | Volume 647 October 2021 |

ISSN 1977-091X

Official Journal

of the European Union

C 405A

English edition

Information and Notices

Volume 647 October 2021

---

| Contents | page |
| --- | --- |
| | V   Announcements |
| | ADMINISTRATIVE PROCEDURES |
| | European Personnel Selection Office (EPSO) |
| 2021/C 405 A/01 | Notice of open competition – EPSO/AD/394/21 – Anti-fraud investigators (AD 7) and Anti-fraud experts (AD 9) in the following fields: Field 1: Anti-fraud investigations and operations in the field of EU expenditure and anti-corruption; Field 2: Anti-fraud investigations and operations in the field of customs and trade, tobacco and counterfeit goods | 1 |
| 2021/C 405 A/02 | Notice of open competition – EPSO/AD/395/21 – Administrators (AD 7) in the following fields: Field 1: Digital forensics, Field 2: Operational and strategic analysis | 29 |

Contents

page

V   Announcements

ADMINISTRATIVE PROCEDURES

European Personnel Selection Office (EPSO)

2021/C 405 A/01

Notice of open competition – EPSO/AD/394/21 – Anti-fraud investigators (AD 7) and Anti-fraud experts (AD 9) in the following fields: Field 1: Anti-fraud investigations and operations in the field of EU expenditure and anti-corruption; Field 2: Anti-fraud investigations and operations in the field of customs and trade, tobacco and counterfeit goods

1

2021/C 405 A/02

Notice of open competition – EPSO/AD/395/21 – Administrators (AD 7) in the following fields: Field 1: Digital forensics, Field 2: Operational and strategic analysis

29

---

| EN | |
| --- | --- |

EN
<PAGE>

32.1     Certification of the Chief Executive Officer and Chief Financial
         Officer of VOXEL pursuant to Section 906 of the Sarbanes Oxley Act
         of 2002


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of VOXEL (the "Company")
for the quarter ended September 30, 1999 as filed with the Securities and
Exchange Commission on the date hereof (the "Report"), the undersigned Michael
Anthony, Chief Executive Officer and Chief Financial Officer of VOXEL, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.

Dated: June 17, 2008

                                      /s/ Michael Anthony
                                      -----------------------
                                      Michael Anthony
                                      Chief Executive Officer


                                      /s/ Michael Anthony
                                      -----------------------
                                      Michael Anthony
                                      Chief Financial Officer
\f.

The. SPifo, c*£ JjImlCl,

l&rftL //)s&n

£A

FILED IN

14th COURT OF APPEALS

HOUSTON TEXAS

^ DEC 10 2015

CHRISTOPHER A. PRINE

CLERK

VMThL i&

h)tn/ .

4- AppallAmis h/2ial jj± dim /la feCMnhoA (7, aoij^

dAflAlhunil kntnJ &

P-l
OSfL 'ihaoo m\oAxrs,i ifWbelL. &VLa ^LoO /TlaJ- Z^yU^ &yn.

Jn/j AI PoAQA/Uih <Q"lr * TTbUl ML jLsJiiJ S}jy\a//A~.f~ ^AOMlt

JOLa JJud^rrdyLcm Cffl 3o cLajuul. fez /kdhj ^hfrZJla OsybJ

/zjy)n I/aTM t jjl l/n /ho&J) cd stAdilLxzvL^J ^DTno ijl Aln€i^^Ji

E/isLat.

9. /LiJjtvAv /lo/aAimaA., £/yx?///tnif /ZahA tka fiaund ifc> ^/2amJ~ a^n

<J, at>rl£jui /2)nh*Lj zt££i- c j7)Lul &^d) faTL^d1 frpoi &/ Zi*

S&mjp jU^jl /OtiajiMJ U<'&- U^ ^ PtoaJtzJ <n/)/)jrs* goo Tt. a

Jjbuj <g D&C. "7s2d)/^* 7& DiiJ-n/r /T/^rJr^ £/}/[/e£Tc>n. fto . Tic.

2-
GLafLfLD* M-fS-oO 7A?~C\/

/?%4&!iL

LOhat i^r PDatoarL hJjtik Zfu^iJm

UUt PAjlUjcttl gILc-iaIa. d_& /hud- /focrt-rt^h> rrtfiLL^\s£SLarf&2^

Zlor \yhhJomj2AJi..

3. P/)flUQ/Lf. f. /fa&uA 'ituA G&u^J-p2sl6sviJ~ 'lJu2 £hfLk tE- /TUJm ±&. t£pJL&(± /to/pjuAiuf* ^
Deo 7, Zml'o

/n^p b/i^l 6^sasD a &u.le 2 PV$&n

SLC 'f*M

CAse: m-is-GGT2_g~c\f

"T^tn ne ^5<?e Colony, T~y,
<~l

V)

\»

NS) t>

JSG*?}-!

k

•3

M5

£*•

.,;.}

O

U

(M

O

M

J 1

1
EXHIBIT 99.1


CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION
906  OF  THE  SARBANES-OXLEY  ACT  OF  2002

     In  connection with the filing of the Quarterly Report on Form 10-Q for the
quarter  ended  June 30, 2003 (the "Report") by Intervest Bancshares Corporation
(the  "Company"),  the  undersigned,  as  the  principal executive and principal
financial  officer  of  the  Company, hereby certifies pursuant to 18 U.S.C. ss.
1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that, to
my  knowledge:

(1)  The  Report  fully complies with the requirements of section 13(a) or 15(d)
     of  the  Securities  Exchange  Act  of  1934;  and

(2)  The  information  contained  in the Report fairly presents, in all material
     respects, the financial condition and results of operations of the Company.

/s/  Lowell  S.  Dansker
------------------------
Lowell  S.  Dansker,  Vice  Chairman,  President  and  Treasurer
(Principal  Executive  and  Financial  Officer)
August  8,  2003


                                       28
<PAGE>
IA 

115TH CONGRESS 

1ST SESSION H. J. RES. 78 

Providing for the reappointment of Stephen M. Case as a citizen regent 

of the Board of Regents of the Smithsonian Institution. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 16, 2017 

Mr. SAM JOHNSON of Texas (for himself, Mr. COLE, and Ms. MATSUI) submitted the following joint resolution; which was referred to the Committee 

on House Administration 

JOINT RESOLUTION 

Providing for the reappointment of Stephen M. Case as 

a citizen regent of the Board of Regents of the Smithsonian Institution. 

1 Resolved by the Senate and House of Representatives

2 of the United States of America in Congress assembled, 

3 That, in accordance with section 5581 of the Revised Stat4 utes of the United States (20 U.S.C. 43), the vacancy on 

5 the Board of Regents of the Smithsonian Institution, in 

6 the class other than Members of Congress, occurring by 

7 reason of the expiration of the term of Stephen M. Case 

8 of Virginia on April 25, 2017, is filled by the reappoint9 ment of the incumbent. The reappointment is for a term 


emcdonald on DSK9F6TC42PROD with BILLS
2 

•HJ 78 IH 

1 of 6 years, beginning on April 26, 2017, or the date of 

2 the enactment of this joint resolution, whichever occurs 

3 later. 

Æ 


emcdonald on DSK9F6TC42PROD with BILLS